YZYBIO-B(02496): The company's H shares have been granted approval for full circulation by the Hong Kong Stock Exchange.
You Ji You Sheng Biology-B (02496) announced that the company was approved by the Hong Kong Stock Exchange on February 4, 2026 to list and trade 68,010,300 H shares (equivalent to the total number of company's non-listed shares convertible and listed for conversion).
YZYBIO-B(02496) announced that the company has been approved by the Hong Kong Stock Exchange on February 4, 2026 to list and trade 68,010,300 H shares (equivalent to the total number of non-publicly traded shares of the company to be converted based on conversion and listing).
Related Articles
QYUNS-B (02509) spent approximately HK$1.8714 million to repurchase 93,000 shares on February 4th.
US Stock Market Move | Raise Annual Revenue Expectations: Super Micro Computer, Inc. (SMCI.US) Surges Over 12% at Opening.
DEEWIN (02418) issued a profit warning. It is expected that the net profit for the year 2025 will be approximately 45 to 55 million yuan, a decrease of about 65% to 71% compared to the same period last year.
QYUNS-B (02509) spent approximately HK$1.8714 million to repurchase 93,000 shares on February 4th.
US Stock Market Move | Raise Annual Revenue Expectations: Super Micro Computer, Inc. (SMCI.US) Surges Over 12% at Opening.
DEEWIN (02418) issued a profit warning. It is expected that the net profit for the year 2025 will be approximately 45 to 55 million yuan, a decrease of about 65% to 71% compared to the same period last year.
RECOMMEND
Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026
Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026
2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026
